“I’m very excited in regards to the potential for Avation’s easy-to-use wearable remedy system,” added Mr. Wennen. “The 42 million Individuals with OAB and UUI have despatched a transparent message that they need an efficient remedy choice that doesn’t require surgical procedure, everlasting implants or the side-effects of treatment. Our system combines non-invasive neuromodulation remedy with a digitally enabled behavioral assist system, providing sufferers a brand new choice that’s efficient, handy, and secure.”
Mr. Wennen brings to Avation Medical a demonstrated historical past of profitable product launches and gross sales progress. Most lately, Mr. Wennen served as VP of Advertising and marketing and Scientific Affairs, in addition to SVP of Industrial Operations, for Tactile Medical (NASDAQ: TCMD), the place he helped to develop an underserved, reimbursement pushed DME wearable market in lymphedema, to develop the corporate to over $200 million in gross sales and to finish an IPO on NASDAQ. Earlier in his profession, Mr. Wennen held management roles with Stryker Orthopedics, Gyrus/ACMI (now Olympus), St. Jude Medical (now Abbott) and Sterilmed (a J&J Firm). Mr. Wennen holds an MBA in advertising and worldwide finance from the College of St. Thomas (St. Paul, MN), and a bachelor’s diploma from the College of Minnesota.
About Avation Medical
Avation Medical is an progressive neuromodulation and digital well being firm with a mission to make neuromodulation extra accessible to sufferers throughout quite a lot of scientific circumstances by eliminating the necessity for surgical procedure, everlasting implants and the side-effects of medicines and shifting remedy to the house setting. The Firm’s novel platform combines non-invasive neuromodulation remedy with digital well being instruments to supply an entire remedy and assist system throughout a spread of continual circumstances. The Firm’s clever wearable remedy objectively confirms activation of the goal nerve, units a personalised therapeutic vary for every affected person, and delivers clinically efficient remedy in simply half-hour. The Firm’s first product, a wearable neuromodulation and digitally enabled conduct assist system for OAB and UUI, is at present accessible for investigational use solely and isn’t FDA cleared.
SOURCE Avation Medical